Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sara Avlund"'
Autor:
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julied Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Bjørn Andersen Nexø, Jacob Sode, Ulla Vogel, Vibeke Andersen
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145302 (2015)
BACKGROUND:The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes and environmental factors. Previous studies have shown that polymorphisms in the Toll-like re
Externí odkaz:
https://doaj.org/article/6adca32d787e468397931117943be910
Autor:
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julie Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Ostergaard Thomsen, Morten Frydenberg, Bjørn Andersen Nexø, Jacob Sode, Ulla Vogel, Vibeke Andersen
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98815 (2014)
The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes and environmental factors. Polymorphisms in genes regulating inflammation may explain part of the geneti
Externí odkaz:
https://doaj.org/article/90b9211ce57a4c46811db2be1a3afde9
Autor:
Hans Jürgen Hoffmann, Natalia Pedersen, Morten Frydenberg, Sara Avlund, Marianne Thomsen, Stine Roug, Jacob Broder Brodersen, Jacob Sode, Ulla Vogel, Vibeke Østergaard Thomsen, Vibeke Andersen, Shaista Rashid, Johan Burisch, Bjørn A. Nexø, Thomas Bastholm Olesen, Stine Ydegaard Turino, Steffen Bank, Britt Kaiser Rasmussen, Julie Galsgaard, Paal Skytt Andersen
Publikováno v:
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Rasmussen, B K, Avlund, S, Olesen, T B, Hoffmann, H J, Thomsen, M K, Thomsen, V Ø, Frydenberg, M, Nexø, B A, Sode, J, Vogel, U & Andersen, V 2014, ' Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease ', Pharmacogenomics Journal, vol. 14, pp. 526–534 . https://doi.org/10.1038/tpj.2014.19
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Rasmussen, B K, Avlund, S, Olesen, T B, Hoffmann, H J, Thomsen, M K, Thomsen, V Ø, Frydenberg, M, Nexø, B A, Sode, J, Vogel, U & Andersen, V 2014, ' Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease ', Pharmacogenomics Journal, pp. 526–534 . https://doi.org/10.1038/tpj.2014.19
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Rasmussen, B K, Avlund, S, Olesen, T B, Hoffmann, H J, Thomsen, M K, Thomsen, V Ø, Frydenberg, M, Nexø, B A, Sode, J, Vogel, U & Andersen, V 2014, ' Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease ', Pharmacogenomics Journal, pp. 526–534 . https://doi.org/10.1038/tpj.2014.19
Antitumor necrosis factor-α (TNF-α) is used for treatment of severe cases of inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). However, one-third of the patients do not respond to the treatment. Genetic
Autor:
Paal Skytt Andersen, Steffen Bank, Hans Jürgen Hoffmann, Natalia Pedersen, Johan Burisch, Jacob Sode, Stine Roug, Vibeke Andersen, Stine Ydegaard Turino, Ulla Vogel, Britt Kaiser Rasmussen, Sara Avlund, Julie Galsgaard, Shaista Rashid, Bjørn A. Nexø, Jacob Broder Brodersen, Thomas Bastholm Olesen
Publikováno v:
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Rasmussen, B K, Avlund, S, Olesen, T B, Hoffmann, H J, Nexø, B A, Sode, J, Vogel, U & Andersen, V 2018, ' Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy ', Pharmacogenomics Journal, vol. 18, no. 1, pp. 87-97 . https://doi.org/10.1038/tpj.2016.84
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Rasmussen, B K, Avlund, S, Olesen, T B, Hoffmann, H J, Nexø, B A, Sode, J, Vogel, U & Andersen, V 2018, ' Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy ', The Pharmacogenomics Journal, vol. 18, no. 1, pp. 87–97 . https://doi.org/10.1038/tpj.2016.84
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Rasmussen, B K, Avlund, S, Olesen, T B, Hoffmann, H J, Nexø, B A, Sode, J, Vogel, U & Andersen, V 2018, ' Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy ', The Pharmacogenomics Journal, vol. 18, no. 1, pp. 87–97 . https://doi.org/10.1038/tpj.2016.84
Anti-tumour necrosis factor-α (TNF-α) is used for treatment of severe cases of inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). However, one-third of the patients do not respond to the treatment. A rece
Autor:
Vibeke Andersen, Paal Skytt Andersen, Steffen Bank, Ulla Vogel, Stine Ydegaard Turino, Hans Jürgen Hoffmann, Natalia Pedersen, Jacob Broder Brodersen, Julied Galsgaard, Shaista Rashid, Jacob Sode, Bjørn A. Nexø, Thomas Bastholm Olesen, Johan Burisch, Stine Roug, Britt Kaiser Rasmussen, Sara Avlund
Publikováno v:
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Rasmussen, B K, Avlund, S, Olesen, T B, Hoffmann, H J, Nexø, B A, Sode, J, Vogel, U & Andersen, V 2015, ' Polymorphisms in the Toll-like receptor and the IL-23/IL-17 pathways were associated with susceptibility to inflammatory bowel disease in a Danish cohort ', P L o S One, vol. 10, no. 12, e0145302 . https://doi.org/10.1371/journal.pone.0145302
PLoS ONE, Vol 10, Iss 12, p e0145302 (2015)
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Ydegaard Turino, S, Broder Brodersen, J, Rashid, S, Kaiser Rasmussen, B, Avlund, S, Bastholm Olesen, T, Hoffmann, H J, Andersen Nexø, B, Sode, J, Vogel, U & Andersen, V 2015, ' Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort ', PLOS ONE, vol. 10, no. 12, e0145302 . https://doi.org/10.1371/journal.pone.0145302
PLoS ONE
PLoS ONE, Vol 10, Iss 12, p e0145302 (2015)
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Ydegaard Turino, S, Broder Brodersen, J, Rashid, S, Kaiser Rasmussen, B, Avlund, S, Bastholm Olesen, T, Hoffmann, H J, Andersen Nexø, B, Sode, J, Vogel, U & Andersen, V 2015, ' Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort ', PLOS ONE, vol. 10, no. 12, e0145302 . https://doi.org/10.1371/journal.pone.0145302
PLoS ONE
BACKGROUND: The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes and environmental factors. Previous studies have shown that polymorphisms in the Toll-like r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8788b62138d9ddde58ecbffbdffea28a
https://curis.ku.dk/ws/files/160855597/Polymorphisms_in_the_Toll_like_receptor_and_the_IL_23.pdf
https://curis.ku.dk/ws/files/160855597/Polymorphisms_in_the_Toll_like_receptor_and_the_IL_23.pdf
Autor:
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julie Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Sara Avlund, Thomas Bastholm Olesen, Anders Green, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Østergaard Thomsen, Bjørn Andersen Nexø, Ulla Vogel, Vibeke Andersen
Publikováno v:
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Avlund, S, Olesen, T B, Green, A, Hoffmann, H J, Thomsen, M K, Thomsen, V Ø, Nexø, B A, Vogel, U & Andersen, V 2015, ' Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases ', Danish Medical Journal, vol. 62, no. 3, A4994 . < http://www.danmedj.dk/portal/page/portal/danmedj.dk/dmj_forside/PAST_ISSUE/2015/DMJ_2015_03/A4994 >
Scopus-Elsevier
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Avlund, S, Olesen, T, Green, A, Hoffmann, H J, Thomsen, M K, Thomsen, V Ø, Nexø, B A, Vogel, U & Andersen, V 2015, ' Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases ', Danish Medical Journal, vol. 62, no. 3 . < http://www.danmedj.dk/portal/pls/portal/!PORTAL.wwpob_page.show?_docname=10693346.PDF >
University of Southern Denmark
Scopus-Elsevier
Bank, S, Andersen, P S, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Turino, S Y, Brodersen, J B, Rashid, S, Avlund, S, Olesen, T, Green, A, Hoffmann, H J, Thomsen, M K, Thomsen, V Ø, Nexø, B A, Vogel, U & Andersen, V 2015, ' Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases ', Danish Medical Journal, vol. 62, no. 3 . < http://www.danmedj.dk/portal/pls/portal/!PORTAL.wwpob_page.show?_docname=10693346.PDF >
University of Southern Denmark
Introduction: The objective of this study was to evaluate the outcome of anti-tumour necrosis factor-α (anti-TNF) treatment in a large cohort of patients with inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::36c51237c6ddb534bc5774318a0d0f81
http://www.danmedj.dk/portal/page/portal/danmedj.dk/dmj_forside/PAST_ISSUE/2015/DMJ_2015_03/A4994
http://www.danmedj.dk/portal/page/portal/danmedj.dk/dmj_forside/PAST_ISSUE/2015/DMJ_2015_03/A4994
Autor:
Shaista Rashid, Morten Frydenberg, Marianne Kragh Thomsen, Vibeke Østergaard Thomsen, Hans Jürgen Hoffmann, Natalia Pedersen, Jacob Sode, Britt Kaiser Rasmussen, Johan Burisch, Julie Galsgaard, Vibeke Andersen, Stine Ydegaard Turino, Paal Skytt Andersen, Steffen Bank, Ulla Vogel, Bjørn A. Nexø, Stine Roug, Thomas Bastholm Olesen, Sara Avlund, Jacob Broder Brodersen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 6, p e98815 (2014)
Bank, S, Skytt Andersen, P, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Ydegaard Turino, S, Broder Brodersen, J, Rashid, S, Kaiser Rasmussen, B, Avlund, S, Bastholm Olesen, T, Jürgen Hoffmann, H, Kragh Thomsen, M, Ostergaard Thomsen, V, Frydenberg, M, Andersen Nexø, B, Sode, J, Vogel, U & Andersen, V 2014, ' Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort ', PLOS ONE, vol. 9, no. 6, e98815 . https://doi.org/10.1371/journal.pone.0098815
Bank, S, Skytt Andersen, P, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Ydegaard Turino, S, Broder Brodersen, J, Rashid, S, Kaiser Rasmussen, B, Avlund, S, Bastholm Olesen, T, Jürgen Hoffmann, H, Kragh Thomsen, M, Ostergaard Thomsen, V, Frydenberg, M, Andersen Nexø, B, Sode, J, Vogel, U & Andersen, V 2014, ' Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort ', PLOS ONE, vol. 9, no. 6, pp. e98815 . https://doi.org/10.1371/journal.pone.0098815
PLoS ONE, Vol 9, Iss 6, p e98815 (2014)
Bank, S, Skytt Andersen, P, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Ydegaard Turino, S, Broder Brodersen, J, Rashid, S, Kaiser Rasmussen, B, Avlund, S, Bastholm Olesen, T, Jürgen Hoffmann, H, Kragh Thomsen, M, Ostergaard Thomsen, V, Frydenberg, M, Andersen Nexø, B, Sode, J, Vogel, U & Andersen, V 2014, ' Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort ', PLOS ONE, vol. 9, no. 6, e98815 . https://doi.org/10.1371/journal.pone.0098815
Bank, S, Skytt Andersen, P, Burisch, J, Pedersen, N, Roug, S, Galsgaard, J, Ydegaard Turino, S, Broder Brodersen, J, Rashid, S, Kaiser Rasmussen, B, Avlund, S, Bastholm Olesen, T, Jürgen Hoffmann, H, Kragh Thomsen, M, Ostergaard Thomsen, V, Frydenberg, M, Andersen Nexø, B, Sode, J, Vogel, U & Andersen, V 2014, ' Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort ', PLOS ONE, vol. 9, no. 6, pp. e98815 . https://doi.org/10.1371/journal.pone.0098815
BACKGROUND: The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes and environmental factors. Polymorphisms in genes regulating inflammation may explain part o
Publikováno v:
Johnsson, A, Avlund, S, Grosen, A & Julsgaard, M 2013, ' Chicken pox infection in a three months old infant exposed in utero to Adalimumab ', Journal of Crohn's & colitis, vol. 7, no. 3, pp. e116-7 . https://doi.org/10.1016/j.crohns.2012.07.020
Dear Sir, Observational data suggest that anti-tumor necrosis factor (TNF)-α antibodies such as Adalimumab (ADA) is safe in pregnancy and that there is no increase in adverse birth outcomes.1 It is believed that ADA efficiently crosses the placenta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732b8a7e9e3720e96a7ec8e20c6abac1
https://pure.au.dk/portal/da/publications/chicken-pox-infection-in-a-three-months-old-infant-exposed-in-utero-to-adalimumab(619ca8cb-cdf2-4808-b7a1-858cef3c18d0).html
https://pure.au.dk/portal/da/publications/chicken-pox-infection-in-a-three-months-old-infant-exposed-in-utero-to-adalimumab(619ca8cb-cdf2-4808-b7a1-858cef3c18d0).html